Evogene Ltd (EVGN) Live Share Price, Invest From India

Evogene Ltd Stock Performance

as on March 20, 2026 at 6:59 am IST

Day's High
$0.83
Day's Price Range
$0.86
$0.83
3.61%
Upside
52 Week's Low
52 Week's High
$0.73
52-Week Price Range
$2.42
$0.83
12.05%
Downside
191.57%
Upside

Evogene Ltd share price movements today

Previous Close: $0.85
Open: $0.85
Volume: 634.9K
Day's Low - High: $0.83 - $0.86
52 Week Low - High: $0.73 - $2.42

Evogene Ltd Historical Returns

1 Month Return: + 3.18 %
3 Month Return: -16.97 %
1 Year Return: -38.64 %
3 Year Return: -86.81 %
5 Year Return: -98.45 %

Evogene Ltd Stock Fundamentals & Key Indicators

Check Evogene Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.8M

EPS (TTM)

-1.5

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-12.9M

Revenue (TTM)

3.9M

Profit Margin

-220.22%

Return On Equity TTM

-100.69%

Evogene Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evogene Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Evogene Ltd	BUY	$7.8M	-98.45%	NA	-220.22%
Alnylam Pharmaceuticals, Inc.	BUY	$41.7B	115.8%	135.11	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$114.7B	111.95%	29.5	32.94%
Beone Medicines Ltd	NA	$32.4B	NA	114.75	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.7B	55.68%	17.95	31.41%

Stock Returns calculator for Evogene Ltd Stock including INR - Dollar returns

The Evogene Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Evogene Ltd investment value today

Current value as on today

₹68,107

Returns

₹31,893

(-31.89%)

Returns from Evogene Ltd Stock

₹39,855 (-39.86%)

Dollar Returns*

₹7,962 (+7.96%)

Analyst Recommendation on Evogene Ltd Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Evogene Ltd. Average target price of $1.75

Evogene Ltd Share Price Target

Get share price movements and forecasts by analysts on Evogene Ltd.

What analysts predicted

52.57%UPSIDE

Target Price

$1.75

Current Price

$0.83

Analyzed by

8 Analysts

Target

$1.75

Evogene Ltd target price $1.75, a slight upside of 52.57% compared to current price of $0.83. According to 8 analysts rating.

Evogene Ltd Stock’s Investor Sentiment and Interest

Search interest for Evogene Ltd Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 18, 2026 to March 20, 2026

Change:-37% versus previous 30 day period

Evogene Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	3	0	4	0	1	1	2	0	0	0
Gross Profit	2	0	3	0	0	0	0	0	0	0
Operating Income	-4	-7	-3	-4	-5	-4	-4	-3	-2	-4
EBITDA	-3	-6	-3	-4	-3	0	-1	-2	-1	-4
Interest Expense	0	0	0	0	2	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-3	-7	-3	-4	-6	0	-2	-3	-2	-5
Income Tax Expense	0	0	0	0	0	0	-	0	0	-
Net Income	-3	-6	-3	-5	-7	0	-2	-4	3	-5
Net Profit Margin	-105.76%	-1142.04%	-92.20%	-895.70%	-438.51%	26.51%	-105.85%	-504.75%	1241.67%	-1690.76%

Evogene Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	6	3	1	0	1	0	1	5	8	3
Gross Profit	0	-1	-1	-2	-2	-2	-1	1	3	0
Operating Income	-21	-21	-21	-22	-26	-31	-29	-26	-21	-13
EBITDA	-17	-18	-18	-15	-23	-27	-26	-23	-15	-12
Interest Expense	0	0	0	0	0	0	0	0	0	1
Depreciation	-	2	2	2	2	2	2	2	2	-
Income Before Tax	-19	-20	-20	-19	-26	-30	-29	-25	-18	-13
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-19	-20	-20	-18	-23	-27	-26	-23	-16	-8
Net Profit Margin	-299.57%	-616.33%	-1188.21%	-2405.31%	-2247.50%	-2988.49%	-1590.33%	-423.39%	-193.69%	-220.22%

Evogene Ltd Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-6	-3	-5	-8	0	-2	-3	-4	-5
Operating Cash Flow	-5	-4	-5	-4	-5	-5	-7	-3	-3
Investing Cash Flow	0	-4	3	2	8	-2	0	11	10
Financing Cash Flow	0	0	0	4	0	0	4	-10	0
Change in Cash	-6	-8	-2	1	3	-7	0	-2	7

Evogene Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-20	-20	-19	-26	-30	-29	-25	-18	-14
Operating Cash Flow	-15	-15	-17	-19	-24	-23	-21	-19	-13
Investing Cash Flow	15	17	37	9	-20	13	-4	9	17
Financing Cash Flow	0	0	9	20	30	9	18	4	-6
Change in Cash	0	2	28	11	-13	-3	-8	-5	-2

Global Institutional Holdings in Evogene Ltd

Funds	Holdings
Morgan Stanley - Brokerage Accounts	0.35%
JPMorgan Chase & Co	0%
Federation des caisses Desjardins du Quebec	0.01%
TWO SIGMA SECURITIES, LLC	0.13%
Advisor Group Holdings, Inc.	0%

See all

Insights on Evogene Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 312.0K → 314.0K (in $), with an average increase of 0.6% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, EVGN stock has moved up by 6.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 65.9% return, outperforming this stock by 152.7%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 22.7% return, outperforming this stock by 61.3%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 3.87M → -5.30M (in $), with an average decrease of 237.0% per quarter

About Evogene Ltd

evogene is a plant genomics company, utilizing a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. evogene offers a complete solution for crop productivity improvement through biotechnology and advanced breeding using a unique technology infrastructure that is based on deep scientific understandings of plant genomics and proprietary computational capabilities. the company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease), in key crops as corn, soybean, wheat and rice. in addition, evogene has earlier stage operations in agriculture chemicals, and seeds focusing on second generation feedstock for biodiesel. the company's headquarters are located in rehovot, israel and is listed for trading on the tel aviv stock exchange (tase: evgn) and on the new york stock exch

Organisation	Evogene Ltd
Headquarters	13 Gad Feinstein Street, Rehovot, Israel, 7638517
Industry	Health Technology
CEO	Mr. Ofer Haviv CPA
E-voting on shares	Click here to vote

Key Management of Evogene Ltd

Name	Title
Mr. Amit Noam Capt. res.	Chief Executive Officer of Lavie Bio Ltd.
Ms. Liat Foigel Wejgman	Vice President of Human Resources
Mr. Russ Putland	Executive VP Commercial & General Manager USA
Ms. Polina Ravzin	Vice President of Finance
Mr. Ofer Haviv CPA	CEO, President & Director
Dr. Elran Hillel Haber M.B.A., Ph.D.	Chief Executive Officer of Biomica Ltd
Mr. Yoash Zohar	Chief Executive Officer of Casterra Ag Ltd.
Dr. Dan Jacob Gelvan Ph.D.	Chief Executive Officer of Ag Plenus Ltd.
Mr. Yaron Eldad	Chief Financial Officer

FAQs

What is Evogene Ltd share price today?

Evogene Ltd share price today is $0.83 as on March 20, 2026 at 1:29 am IST at the close of the market. Evogene Ltd share today touched a day high of $0.86 and a low of $0.83.

What is the 52 week high and 52 week low for Evogene Ltd share?

Evogene Ltd share touched a 52 week high of $2.42 on June 10, 2025 and a 52 week low of $0.73 on March 11, 2026. Evogene Ltd stock price today i.e. March 20, 2026 at 1:29 am IST is closed at $0.83,which is 65.70% down from its 52 week high and 13.70% up from its 52 week low.

What is Evogene Ltd's market capitalisation today?

Evogene Ltd market capitalisation is $0.00T as on March 20, 2026 at 1:29 am IST.

How to invest in Evogene Ltd Stock (EVGN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Evogene Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evogene Ltd Shares that will get you 1.8072 shares as per Evogene Ltd share price of $0.83 per share as on March 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy Evogene Ltd Stock (EVGN) from India?

Indian investors can start investing in Evogene Ltd (EVGN) shares with as little as ₹93.193 or $1 (as of March 20, 2026 at 3:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹931.93 in Evogene Ltd stock (as per the Rupee-Dollar exchange rate as on March 20, 2026 at 3:39 pm IST). Based on Evogene Ltd share’s latest price of $0.83 as on March 20, 2026 at 1:29 am IST, you will get 12.0482 shares of Evogene Ltd. Learn more about fractional shares .

What are the returns that Evogene Ltd has given to Indian investors in the last 5 years?

Evogene Ltd stock has given -98.45% share price returns and 27.41% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?